European Healthtech startup funding raised during October 2022.
In October 2022, 66 European Healthtech companies raised a combined €726M across 66 funding rounds, down 14.8% versus October 2021. Switzerland led by capital raised, and Biopôle Start-up Fund was the most active investor. Data as of 9 Jul 2026.
6 exits · €322M disclosed.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Vectivbio | Other | Oct 2022 | €127M |
| Resolve Biosciences | Series B | Oct 2022 | €72M |
| Univercells | Other | Oct 2022 | €44M |
| Nucleome Therapeutics | Series A |
| Oct 2022 |
| €38M |
| anokion | Other | Oct 2022 | €36M |
| Mablink Bioscience | Series A | Oct 2022 | €31M |
| Aqemia | Series A | Oct 2022 | €30M |
| Patronus | Series A | Oct 2022 | €27M |
| Micreos | Other | Oct 2022 | €25M |
| Araris Biotech | Other | Oct 2022 | €24M |
| Sibylla Biotech | Series A | Oct 2022 | €23M |
| Bob W | Series A | Oct 2022 | €21M |
| anvajo | Other | Oct 2022 | €18M |
| SpinDiag | Debt | Oct 2022 | €15M |
| OpenUp | Series A | Oct 2022 | €15M |
